Beijing Lideman Biochemical Co., Ltd. has recently received an invention patent certificate from the National Intellectual Property Administration for a rapid detection kit for soluble ST2 levels. The patent, numbered ZL 2023 1 0228832.8, aims to enhance detection accuracy and reduce testing time. While this patent will not significantly impact the company's current operations, it strengthens its intellectual property protection and promotes technological innovation.
Summary generated by AI · Always verify with source document
Beijing Lideman Biochemical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
The Company has recently received one "Invention Patent Certificate" issued by the National Intellectual Property Administration. The details of the acquired patent are as follows:
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.